|
|
Insulin Resistance and the Cardiometabolic Syndrome:
Adipose Tissue and Skeletal Muscle Factors
Sponsored by
APS Endocrinology & Metabolism
Section
Metabolic Abnormalities Track
Sunday, April 29 — 3:15-5:15 PM
Washington, DC Convention Center — Room 145A
|
| Chaired: |
James R. Sowers, Univ. of Missouri,
Columbia
Craig S. Stump, Univ. of Missouri, Columbia |
Skeletal muscle constitutes the tissue
that is primarily responsible for insulin stimulated glucose utilization.
Further, skeletal muscle insulin resistance is fundamental to the metabolic
dysregulation associated with obesity and physical inactivity, and
contributes to the development of type 2 diabetes mellitus and the
cardiometabolic syndrome. This symposium will discuss potential mediators
of the insulin resistance that occurs with adipose tissue expansion and
central distribution including intramuscular lipid accumulation, increased
renin-angiotensin system and inflammatory cytokine pathways, and increased
oxidative stress. We will also explore strategies to maintain or improve
skeletal muscle metabolic flexibility and insulin sensitivity including
adequate physical activity, healthy weight and specific pharmacologic
interventions.
|
3:15 PM |
Regional adiposity: does location matter?
Michael D. Jensen, Mayo Clinic
|
|
3:40 PM |
Intramuscular lipid metabolism, insulin action,
and obesity.
Joe Houmard, East Carolina Univ.
|
|
4:05 PM |
Metabolic responses of skeletal muscle to
contractile activity.
John Thyfault, Univ. of Missouri, Columbia
|
|
4:25 PM |
Improving insulin sensitivity by inhibiting the
renin-angiotensin system.
Erik J. Henriksen, Univ. of Arizona
|
|
4:50 PM |
Skeletal muscle insulin resistance: role of
inflammatory cytokines and reactive oxygen species.
Yongzhong Wei, Univ. of Missouri, Columbia
|
|
|